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Abstract
Introduction: The novel coronavirus (SARS-CoV-2) is infecting people and spreading easily from person-to-person.
Cases have been detected in most countries worldwide. Italy is one of the most affected countries as of 30 March 2020.
Public health response includes a rapid reorganization of the Italian National Healthcare System in order to reduce
transmission of COVID-19 within hospitals and healthcare facilities, while optimizing the assistance to patients with
severe COVID-19 complications.
Methods: We analysed the actions that were taken in three ophthalmology centres in northern Italy during the SARS-
CoV-2 outbreak and how these measures affected patient’s attendance. In addition, due to the rapidly evolving scenario,
we reviewed the evidence available during the course of this pandemic.
Results: A full reorganization of ophthalmology services is mandatory according to current existing infection contain-
ment measures in order to continue dispensing urgent procedures without endangering the community with amplifi-
cation of the diffusion chain. Ophthalmologists are considered at elevated risk of exposure when caring patients and vice
versa, due to their close proximity during eye examination. High volumes of procedures typically generated by oph-
thalmologists with concurrent implications on the risk of infection are considered when re-assessing healthcare facilities
reorganization.
Conclusion: Containment measures in the event of pandemic due to infective agents should be well known by
healthcare professionals and promptly applied in order to mitigate the risk of nosocomial transmission and outbreak.
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Introduction
In December 2019, an atypical pneumonia of unknown
origin was first reported in a group of patients in
Wuhan, China.1 Chinese authorities identified a new
betacoronavirus (severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2)) as the cause of the out-
break.2 SARS-CoV-2 is highly contagious and has
evolved into a global health threat within weeks. As
of 30 March 2020, the ongoing outbreak of coronavi-
rus disease 2019 (COVID-19) originating in Wuhan
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had caused more than 770,000 confirmed cases and
more than 37,000 deaths, with 178 countries/sovereign-
ties affected worldwide.3 At the same date, Italy was
one of the most affected countries with more than
100,000 confirmed cases and more than 11,000
deaths. Cities like Milan, Bergamo and Brescia, in
Lombardy, reported an exponential growth of hospi-
talized people infected by SARS-CoV-2. Since 10
March 2020, Italy has been on lockdown. Schools, uni-
versities, museums and most shops have been closed
and the National Healthcare System is trying to cope
with the flood of patients needing hospitalization and
intensive care unit support.4 The emergence of a novel
viral pneumonia constitutes an unprecedented threat
and challenge to the community as well as to the
healthcare system. Strong hygiene and containment
measures and individual citizen responsibility, includ-
ing strict self-isolation measures, have been instituted
to slow down virus transmission. Also, a rapid infec-
tion control response is essential to contain and miti-
gate the risk of nosocomial transmission and outbreak.
In light of this, since the lockdown, we rapidly modified
the organization of our ophthalmology clinics in order
to stepping up control measures for SARS-CoV-2
infection. Working modalities are continuously evolv-
ing according to local regulations and available guide-
lines. This article aims to share the local experience of
three centres in northern Italy (Department of
Ophthalmology, University Vita-Salute, IRCCS
Ospedale San Raffaele, Milan; Department of
Ophthalmology, ASUFC, Udine; and Istituto
Europeo di Microchirurgia Oculare (IEMO), Udine)
in order to educate ophthalmologists on necessary
measures to minimize impact on both healthcare work-
ers and patients. Transitional adopted measures are
also discussed with respect to recent published data.
Methods
A review of relevant documents through Internet and
database search was conducted in relation to SARS-
CoV-2. Pertinent evidence was selected in order to
implement strategies to avoid virus infection in
ophthalmology. We describe the scenario of three oph-
thalmology centres in northern Italy during the SARS-
CoV-2 outbreak. The Department of Ophthalmology
of the University Vita-Salute, IRCCS Ospedale San
Raffaele is located in Milan, a city with 1.3 million
inhabitants and a dense and extended urban region
with a total population of 5 million people which has
already been hit hard by the COVID-19 outbreak. The
Department of Ophthalmology of ASUFC is located in
Udine, a city with 100,000 inhabitants and serves
Italy’s north-easternmost region (1.2 million inhabi-
tants). In this region, the COVID-19 epidemic curves
are not yet as dramatic as in Milan and Lombardy,
with a slower increase rate. IEMO is also located in
Udine. It is an ambulatory surgery centre (ASC)
focused on providing same-day diagnostic and surgical
care, especially for retinal conditions and intravitreal
therapies. We analysed the actions that were taken in
the above cited centres and how these measures affect-
ed patient’s attendance. In addition, due to the rapidly
evolving scenario, we reviewed the evidence available
during the course of this pandemic.
Observation
COVID-19: the epidemic and the challenges
The SARS-CoV-2 was found to be a positive-sense
single-stranded RNA virus belonging to the genus
Betacoronavirus. Based on the observation of data,
the trend in an increasing incidence largely follows
exponential growth. The current estimate of the mean
incubation period for the COVID-19 was 6.4 days,
which ranges from 2.1 to 11.1 days.5,6 SARS-CoV-2
is spread by human-to-human transmission via drop-
lets or direct contact. Several reports suggest that the
virus can cause conjunctivitis and possibly be transmit-
ted by aerosol contact with conjunctiva.7,8 Despite rec-
ognition that transmission occurs mostly via
symptomatic individuals, there are reports of asymp-
tomatic individuals who infected multiple family mem-
bers.9–11 These reports underscore the need for
prevention of cross-infection. Evidence related to trans-
missibility and mortality alert the healthcare communi-
ty of the importance of vigilance, preparation, active
management and protection. In high-risk sites and clin-
ical settings, where crowding is identified as a major
concern, rigour in the use of recommended precautions
for all patients including public health and infection
control measures is urgently needed. At the time of
the latest revision of this article (22 April 2020), tens
of thousands of healthcare workers have developed
infection internationally, including 3400 in China and
more than 15,000 in Italy, as well as thousand of infec-
tions in Americans. Latest estimates from Lombardy
suggest that 20% of healthcare professionals are posi-
tive for SARS-CoV-2. To date, more than 140 doctors
(including one ophthalmologist) died from COVID-19
in Italy and among the healthcare workers who died in
Wuhan, three were Chinese ophthalmologists, includ-
ing Dr Li Wenliang, who was probably infected while
treating an asymptomatic glaucoma patient.12,13 It is
essential to limit human-to-human transmission, to
reduce secondary infections among healthcare workers
and prevent transmission amplification events within
hospitals and health services. Since the end of
February, hospitals in northern Italy have been
2 European Journal of Ophthalmology 0(0)
reorganized. Most of them have special areas for
COVID-19 patients. Some hospitals are acting as
hubs to collect patients with COVID-19 and related
diseases. Most of the outpatient clinics have been
shut down and non-urgent visits are postponed to
make resources available for the most severe cases.
While the situation is evolving rapidly, newer docu-
ments and guidelines are available to advice on best
practice.
Strategies to prevent transmission in
ophthalmology clinics
We present a real-life scenario on reorganization of
clinical activity at our clinics in order to:
1. Prevent nosocomial transmission amplification
events.
2. Provide adequate care of patients with non-
deferrable ocular conditions.
3. Facilitate the conversion of a routine care hospital
to a hub hospital for assisting patients experiencing
COVID-19 complications.
Strategies from all the three ophthalmic centres were
generally consistent with some differences that will be
detailed below and summarized in Table 1.
Minimize chance for exposures. Avoid hospital-related
transmission of the virus. Enforce facility policies and
practices to minimize exposures to SARS-CoV-2.
Implement measures even before patient arrival with
the aim of lowering patient attendance. We applied
the following actions:
• Suspension of elective clinical services and resched-
uling appointments to patients with non-urgent con-
ditions. Due to the relevant volume of subjects
attending the outpatient service, selected physicians
(including residents), nurses and administrative per-
sonnel have been dedicated to screen patients’
records and to contact scheduled patients via
phone. In routine conditions, 3000 patients at the
hospital in Milan, 590 patients at the hospital in
Udine and 110 patients at the ASC are typically
scheduled for an ophthalmic evaluation or a diag-
nostic procedure in 1 week. Within the first week of
the outbreak, a reduction in patients’ attendance by
70%–80% was attained in all institutions. Six hun-
dred patients in Milan, 113 patients at the Udine
hospital and 30 patients in the ASC were seen due
to urgent ocular conditions or underwent non-
deferrable diagnostic exams.
• As for surgery, cataract interventions and other elec-
tive procedures have been postponed. Intravitreal
therapies were maintained to avoid any delay.
There are two reasons for not deferring intravitreal
injections. Any delay may possibly cause both ana-
tomical and functional irreversible worsening.
Furthermore, rescheduling high volumes of injec-
tions poses challenges on capacity and available
slots. Cancellation of elective surgeries allowed to
increase the interval between procedures avoiding
massive presence of patients at the clinics and hope-
fully reducing the risk of infection. Under normal
circumstances, 141 patients in Udine and 330
patients in Milan undergo surgical procedures or
intravitreal injections per week. Within the first
week of the Italian outbreak, after rescheduling, 71
patients at the Udine hospital and 80 in Milan
underwent non-deferrable surgical procedures (reti-
nal detachment surgery, glaucoma surgery, ocular
oncology surgery, trauma) and intravitreal
injections.
Scheduled intravitreal injections were mostly main-
tained at the ASC. A number of patients planned for
intravitreal therapies at the hospital centres cancelled
their appointments. This rate was higher in the Milan
centre due to the subset of population referring to the
San Raffaele Hospital. Those patients are often
residents from other Italian regions who
experienced major difficulties in travelling during the
outbreak and were at high risk of quarantine
after their return home. Some patients skipped the
appointment because they did not perceive the urgency
of the therapy.
Fortunately, the total time spent at the health facil-
ities for receiving intravitreal therapies did change after
the outbreak and lockdown. At the hospitals and ASC,
respectively, the mean total time decreased from 185 to
102 min and from 1 h to 32 min.
The recently released recommendations from the
American Academy of Ophthalmology (AAO) list
elective/non-urgent and elective urgent procedures.
Among the non-urgent procedures are: strabismus sur-
gery, standard cataract extraction, lid surgery/blepha-
roplasty, cosmetic oculoplastics, intraocular lens
exchange, refractive surgery, large and stable macular
hole repair and stable epiretinal membrane peel. Poorly
controlled glaucoma surgery, macula-off retinal
detachment repair, orbital biopsy, optic nerve sheath
fenestration, congenital cataract and other non-
deferrable procedures are considered as elective
urgent procedures. Macula threatening retinal detach-
ment, endophthalmitis and open globe repair/full-
thickness corneal laceration are considered urgent/
emergent surgeries. The abovementioned recommenda-
tions state that ‘urgency’ is determined by physician
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judgement and must always take into account individ-
ual patient medical and social circumstances.14
• In order to minimize the influx of patients and care-
givers, guidance is given to convert all accesses that
do not strictly require a visit of the patient into a
phone contact.
Patient triage. It is particularly important to protect
individuals at increased risk for adverse outcomes
from COVID-19 (e.g. older individuals with comorbid
conditions). In order to protect the patients attending
the clinic and the healthcare staff, a rapid safe triage
and isolation of patients with symptoms of suspected
COVID-19 or other respiratory infections (e.g. fever
and cough) are mandatory. We implemented the fol-
lowing steps:
• A triage station is set up outside the facility to screen
patients prior to entering the clinic.
• Physical barriers are installed (e.g. glass or plastic
windows) at reception areas to limit close contact
between triage personnel and potentially infectious
patients.
• Visual alert icon (e.g. signs and posters) at the entrance
and in strategic places (e.g. waiting areas and
elevators) is posted to provide patients and healthcare
professionals with instructions about hand hygiene,
respiratory hygiene and cough etiquette.
• Supplies for respiratory hygiene and cough etiquette,
including alcohol-based hand rub with 60%–95%
alcohol, tissues and no-touch receptacles for dispos-
al, are positioned at entrances, waiting rooms and
patient check-ins.
• Access is limited only to patients with non-deferrable
ocular conditions. Presence of caregivers, if not strict-
ly necessary, is not allowed inside the clinic. When
needed, only one accompanying person is permitted.
• Triage of patients with respiratory symptoms is
prioritized.
• At the time of check-in, patients are asked about the
presence of symptoms of a respiratory infection and
history of travel to areas experiencing transmission
of COVID-19 or contact with possible COVID-19
cases in the past 14 days.
• Triage personnel wear surgical face masks. These are
also provided to patients with symptoms of respiratory
infection at check-in. At the ASC, all patients received
a face mask and were instructed on how to wear it.
The importance of triage is highlighted by all recom-
mendations from different scientific communities.14–17
Table 1. Summary of recommendations.










Minimize chance for exposures
Suspension of elective clinical services Supported Supported Supported
Suspension of elective surgical procedures Supported Supported Supported
Maintain intravitreal therapies Not mentioned Supported Supported
Patient triage
Safe triage and isolation of patients with symptoms
of suspected COVID-19 or other respiratory infection
Supported Supported Supported
Reduction of droplet generation and infection transmission
Promote cough etiquette and hand hygiene Supported Supported Supported
Slit-lamp barriers Supported Supported Supported
Avoid speaking during slit-lamp examination Supported Not mentioned Supported
Prefer contact tonometry Not mentioned Not mentioned Not mentioned
Use of personal protective equipment
Face masks for symptomatic patients Supported Supported Supported









Environmental control Supported Supported Supported
Staff education Supported Supported Supported
Patient education Not mentioned Not mentioned Supported
AAO: American Academy of Ophthalmology; RCOphth: The Royal College of Ophthalmologists; SOI: Società Oftalmologica Italiana; AIMO:
Associazione Italiana Medici Oculisti.
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Reduction of droplet generation and infection transmission. As
the model of transmission is mainly by droplets, we
introduced the following measures:
• The waiting rooms are kept as empty as possible by
increasing the interval time between appointments,
and as much as prudent, the visits of the most vul-
nerable patients are reduced.
• We identified a separate, well-ventilated space that
allows the waiting patients to be separated by 6 or
more feet, with easy access to respiratory hygiene
supplies.
• Cough etiquette is promoted.
• Hand hygiene by hand sanitizing with alcoholic sol-
utions is performed. Soap and water are used if
hands are visibly soiled. Meticulous hand hygiene
is strongly recommended during the following
steps: before and after all patient contact; before
and after using a surgical mask and after removing
gloves; after having contact with respiratory and lac-
rimal secretions and objects/materials in the envi-
ronment surrounding the patient.
• We designed and installed disposable slit-lamp plas-
tic barriers as they may provide a measure of added
protection against droplet transmission.18,19
• Patients and physicians are strongly recommended
to avoid speaking during slit-lamp examination.
• Non-contact tonometry (NCT) is a potential source
of microaerosol.20 Therefore, it is prudent to sus-
pend the use of NCT in outbreak areas. I-Care
tonometry or Goldmann applanation tonometry
with the use of disposable tips are encouraged to
minimize the risk of cross-infection.
An additional preventive action is to reduce time in
close contact during examination as illustrated in the
key actions by the Royal College of Ophthalmology.15
Use of personal protective equipment. Healthcare person-
nel are on the front lines of caring for patients with
confirmed or possible infection with COVID-19 and
therefore have an increased risk of exposure to this
virus. Moreover, it is estimated that a high percentage
of healthcare personnel working in outbreak areas are
positive for SARS-CoV-2. Eye examinations typically
require less than 3-feet face-to-face distance. Therefore,
the correct use of personal protective equipment (PPE)
is mandatory in order to prevent nosocomial amplifi-
cation events in ophthalmology.
Theoretically, gown, gloves, protective mask and
goggles or some sort of good eye protection are recom-
mended. However, many hospitals in Italy and Europe
have reported shortages of PPE, specifically N95 respi-
rators and face masks. In this scenario, alternatives are
considered, including other classes of face masks.
Special care is taken to ensure that respirators are
reserved for situations where respiratory protection is
most important, such as during aerosol-generating pro-
cedures on suspected or confirmed COVID-19 patients.
Physicians and staff wear gloves before touching any
patients with conjunctivitis. Attention is paid to train-
ing and proper donning, doffing and disposal of any
PPE. A recent systematic review21 found that frequent
hand washing, barrier measures including gloves and
masks and isolation of people with suspected respira-
tory tract infection reduce the transmission of respira-
tory viruses. Although the protective effect of surgical
masks against relevant aerosolized biological hazards is
limited, they are still protective to some extent.22–24
In Italy, 44% of the laboratory-confirmed cases
have been asymptomatic.25,26 It has also been reported
that some asymptomatic patients have a viral load sim-
ilar to those with symptoms and that infected persons
could transmit infection before symptoms
appear.11,14,26 Therefore, the use of face masks is rea-
sonable when visiting asymptomatic patients at the slit
lamp. Current guidelines of the AAO for urgent oph-
thalmology appointment for a patient with no respira-
tory illness symptoms, no fever and no COVID-19 risk
factors indicate that masks, gown and gloves are not
routinely required for patient or clinician but may
reduce asymptomatic transmission. The key actions
from the Royal College of Ophthalmologists suggest
the use of surgical face masks at discretion during stan-
dard slit-lamp examination and the use of surgical face
mask in case of prolonged close exam, for example,
panretinal photocoagulation (PRP) laser.15 Also,
local regulations may influence the use of PPE.
Environmental control. Rooms and instruments are thor-
oughly disinfected after each patient encounter. Wear
disposable gloves when cleaning and disinfecting surfa-
ces. Slit lamps, including joystick and other controls,
and accompanying breath shields, are disinfected. With
the use of disposable tips in tonometry, the risk of
cross-infection is minimized.19 A full list of antimicro-
bial products expected to be effective against COVID-
19 is available online.27 Clinical documentation is
completed using electronic medical records. Attention
is paid to computer mouse and keyboard disinfection.
Clinical staff clean workspaces and personal items such
as stethoscopes, mobile phones, dictation devices, land-
lines, name tags and other items with appropriate dis-
infectants. Environmental service workers increase the
frequency of cleaning of commonly touched surfaces
such as light switches, countertops, chair arms, elevator
buttons, doorknobs and handles. Active decontamina-
tion is not merely a technical issue; it is also reassuring
to stressed and concerned caregivers, patients and
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visitors. The importance of environmental control is
also highlighted by recent recommendations.14–17
Staff education, infection control training and symptom
monitoring. All staff undergo infection control training
to familiarize with the proper steps of hand hygiene
and donning and doffing of PPE. All clinical staff are
required to report any symptoms such as fever, chills,
myalgia, sore throat, runny nose, cough, vomiting,
diarrhoea or pneumonia as well as on their recent
travel histories. We schedule daily virtual meetings to
allow staff to receive updated instructions, and share
information and data without being physically
grouped together. We utilize a free multi-platform
online service.
Patient education. Considering the multitude of contacts,
it is the responsibility of the staff to provide patient
education in order to improve social behaviour and
disease understanding:
• Educate to social distancing measures, following
Government and Health Authorities’ instructions.
• Educate patients to proper eye drop administration
technique. Promote self-instillation.
• Educate eyeglass wearers to disinfect spectacles and
glasses. Attention is paid at presbyopic patients
using reading glasses, as they may be putting them
on and off their face multiple times a day. Promote
careful and thorough hand washing.
• Educate contact lens users to proper hand washing
before and after insertion and removal.
Additional measures to be considered. The following meas-
ures are not yet applied to our centres. However, there
is a rationale for their adoption in a clinical setting:
• At arrival, all patients and their accompanying per-
sons could be screened using infrared thermometers.
• Electronic messaging services – such as short mes-
saging service (SMS), messaging apps or chatbots –
could be used in order to provide prompt and useful
information to patients.
• When physical barriers are not present between
patients and the admittance staff, alternative meas-
ures are adopted such as social distancing (at least 3–
6 feet), avoidance of any direct and indirect contact.
Discussion
As of 30 March 2020, more than 11,000 subjects have
been killed in Italy and 37,000 worldwide by COVID-
19, which has had the worst outbreak outside of main-
land China.3 Unlike the Great War, this battle cannot
be fought with traditional arms, as very few are known
about the enemy and how to fight it. The only weapon
that we currently have to avoid the collapse of health-
care services is to reduce the spread of this novel virus
through containment measures to mitigate the risk of
nosocomial transmission. It is critically important to
implement proactive infection control actions, which
must be planned ahead. There is a massive risk of
paying a high price for the lack of training, appropriate
tools and proper plans.
Ophthalmologists are at elevated risk of exposure
when caring patients, because they work in close prox-
imity to patients and serve as the first providers to
evaluate COVID-19 positive patients with conjunctivi-
tis. Ophthalmologists usually visit a high volume of
patients over the age of 60 years, putting them at
increased risk of developing COVID-19. Providing
patients with a face mask, supplying tissues, promoting
cough etiquette and recommending hand hygiene and
applying decontamination are all important steps. All
healthcare personnel should be aware that they may
become a major source of contamination in case they
do not attain to simple and yet efficacious hygiene
rules. Frequent information and feedback sessions,
complemented by clear, concise and measured commu-
nication via virtual meetings, will help staff stay
focused.
ASCs may react more promptly to pandemic than
hospitals due to their lower complexity and confined
spaces which enable prompt application of contain-
ment measures. During emergency conditions, hospital
administrators may consider to reallocate specific pro-
cedures such as intravitreal therapies to ASCs in order
to limit patients’ access to hospitals, where the risk of
being exposed to the infecting agent is higher. We hope
that our early experience in enhancing infection control
measures in ophthalmology can help physicians to
optimally reorganize patient care.
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